P69 Moderate resuscitative hypothermia after brain trauma (simulated epidural hematoma) in new intensive care outcome model in dogs

Resuscitation ◽  
1994 ◽  
Vol 28 (2) ◽  
pp. S13 ◽  
Author(s):  
U. Ebmeyer ◽  
P. Safar ◽  
S. Pomeranz ◽  
S. Tisherman ◽  
A. Radovsky ◽  
...  
BMJ ◽  
1999 ◽  
Vol 319 (7204) ◽  
pp. 241-244 ◽  
Author(s):  
K. Gunning ◽  
K. Rowan

2006 ◽  
Vol 33 (3) ◽  
pp. 524-528 ◽  
Author(s):  
Luc Jacquet ◽  
Olivier Vancaenegem ◽  
Jean Rubay ◽  
Fatima Laarbaui ◽  
Céline Goffinet ◽  
...  

2014 ◽  
Vol 15 (3) ◽  
pp. 205-212 ◽  
Author(s):  
Robert Docking ◽  
Andrew Mackay ◽  
Claire Williams ◽  
Jim Lewsey ◽  
John Kinsella ◽  
...  

1999 ◽  
Vol 27 (Supplement) ◽  
pp. A53
Author(s):  
James Y Findlay ◽  
J. Louie Plenderleith

PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0206862 ◽  
Author(s):  
Christopher Meiring ◽  
Abhishek Dixit ◽  
Steve Harris ◽  
Niall S. MacCallum ◽  
David A. Brealey ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
S. A. Prins ◽  
S. J. A. Pans ◽  
M. M. van Weissenbruch ◽  
F. J. Walther ◽  
S. H. P. Simons

Apnoea of prematurity is treated with noninvasive respiratory therapy and methylxanthines. For therapy unresponsive apnoea doxapram is often prescibed in preterm neonates. The duration, dosage and route of administration of doxapram together with its efficacy was evaluated in two Dutch neonatal intensive care. Outcome concerning short-term safety and neonatal morbidity were evaluated. During 5 years, 122 of 1,501 admitted newborns <32 weeks of gestational age received doxapram. 64.8% of patients did not need intubation after doxapram. 25% of treated neonates were <27 weeks of gestation. A positive response to doxapram therapy on apnoea was associated with longer duration of doxapram usage (P<0.001), lower mean doses (P<0.003), and less days of intensive care (median 33 versus 42 days;P<0.002). No patients died during doxapram therapy. Incidence of necrotizing enterocolitis, intraventricular hemorrhage, periventricular leukomalacia, retinopathy of prematurity, persistent ductus arteriosus, or worsening of pulmonary condition did not increase during doxapram therapy. Doxapram is frequently used for apnoea of prematurity, despite a lack of data on short-term efficacy and long-term safety. Until efficacy and safety are confirmed in prospective trials, doxapram should be used with caution.


2011 ◽  
Vol 6 (1) ◽  
Author(s):  
Fabian Doerr ◽  
Akmal MA Badreldin ◽  
Matthias B Heldwein ◽  
Torsten Bossert ◽  
Markus Richter ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document